Susquehanna reiterated their neutral rating on shares of Humana Inc. (NYSE:HUM) in a research note released on Thursday. Susquehanna currently has a $180.00 price objective on the insurance provider’s stock.
A number of other equities analysts have also commented on HUM. Cantor Fitzgerald reissued a buy rating on shares of Humana in a research note on Saturday, July 9th. RBC Capital Markets reissued a buy rating and issued a $224.00 price objective (up previously from $220.00) on shares of Humana in a research note on Friday, July 22nd. Royal Bank Of Canada reduced their price objective on Humana from $222.00 to $217.00 and set a sector perform rating on the stock in a research note on Thursday. Jefferies Group dropped their target price on Humana from $220.00 to $217.00 and set a buy rating for the company in a research report on Thursday, August 4th. Finally, Barclays PLC dropped their target price on Humana from $193.00 to $191.00 and set an equal weight rating for the company in a research report on Thursday, August 4th. Seven analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus price target of $200.50.
Humana (NYSE:HUM) traded up 1.82% during trading on Thursday, hitting $172.57. The company had a trading volume of 381,454 shares. The firm has a 50-day moving average of $176.12 and a 200 day moving average of $175.83. The company has a market capitalization of $25.72 billion, a price-to-earnings ratio of 26.51 and a beta of 0.90. Humana has a 12-month low of $150.00 and a 12-month high of $191.65.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. The company had revenue of $14 billion for the quarter, compared to analyst estimates of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business’s revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.67 earnings per share. On average, equities research analysts forecast that Humana will post $9.24 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be given a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 annualized dividend and a dividend yield of 0.68%. Humana’s dividend payout ratio is currently 18.18%.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Daiwa SB Investments Ltd. boosted its position in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares in the last quarter. Northwestern Mutual Investment Management Company LLC boosted its position in Humana by 0.4% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 5,684 shares of the insurance provider’s stock valued at $1,022,000 after buying an additional 22 shares in the last quarter. Fifth Third Bancorp boosted its position in Humana by 0.5% in the second quarter. Fifth Third Bancorp now owns 4,547 shares of the insurance provider’s stock valued at $818,000 after buying an additional 23 shares in the last quarter. Savant Capital LLC boosted its position in Humana by 1.3% in the second quarter. Savant Capital LLC now owns 2,380 shares of the insurance provider’s stock valued at $428,000 after buying an additional 30 shares in the last quarter. Finally, Cleararc Capital Inc. boosted its position in Humana by 0.9% in the second quarter. Cleararc Capital Inc. now owns 3,630 shares of the insurance provider’s stock valued at $653,000 after buying an additional 31 shares in the last quarter. 93.24% of the stock is owned by institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.